Protier Biotech

Seed
protierbiotech.com Biotech & Healthcare Seoul, South Korea
Total Funding $2.4M
Latest Round $2.3M Seed
Last Announced Apr 6, 2026
Investors Undisclosed
Decision Makers Profile Active

About Protier Biotech

Protier Biotech is focusing on developing innovative anticancer drugs that overcome the limitations of existing treatments.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Seoul, South Korea
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website protierbiotech.com
Domain Registered Date May 1, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $2,350,000 · Seed

    news.google.com

  2. Milestone

    Website domain registered

    protierbiotech.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Protier Biotech.

Funding History

1 Round
Seed equity · Apr 6, 2026

Founders & Leadership

1

Kim Tae

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts